A Phase I/II Study of Lenalidomide and Obinutuzumab With CHOP for Diffuse Large B Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Safety and Efficacy of an Immunoablative Nonmyeloablative Conditioning Protocol for Autologous Bone Marrow Transplantation (BMT) in Patients With Multiple Sclerosis (MS)
- Status
- UNKNOWN
- Phase
- NA
CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Dasatinib Combined With Chemotherapy in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Study of Isatuximab Combined With Bortezomib + Cyclophosphamide + Dexamethasone (VCD) and Bortezomib + Lenalidomide + Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma (MM) Non Eligible for Transplant or No Intent for Immediate Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant FDC With Melatonin or Metformin for Locally Advanced Breast Cancer.
- Status
- UNKNOWN
- Phase
- PHASE2
Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Pembrolizumab, Standard Chemotherapy, Tumor Infiltrating Lymphocytes, and High- or Low-Dose Aldesleukin in Treating Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
In Vivo Persistence of Adoptively-Transferred TIL Cultured With Akti in People With Metastatic Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
MabThera (Rituximab) in Combination With CHOP (or CHOP-like) Chemotherapy in Patients With Aggressive B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- N/A
TIL Therapy for Metastatic Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study To Examine Toxicity Of Allogeneic Stem Cell Transplantation For Relapsed Or Therapy Refractory Ewings Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1
Relapse Myeloma; Cyclofosfamide; Bortezomib; Maintenance
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1